Moderna (MRNA) is back in focus after completing a clinical study of multiple mRNA vaccines targeting several respiratory diseases, alongside fresh regulatory attention on mRNA products from U.S.

Minnesota Governor Tim Walz defended his state during a tense House Oversight and Government Reform Committee hearing on ...

The Idaho Medical Association previously filed a complaint against the pathologist for prescribing ivermectin as a treatment ...

Investors in BioNTech SE were confronted with a dual challenge last week, triggering a dramatic single-day sell-off that saw the company's stock plummet more th ...

Despite a slew of health-related problems facing Louisianans — like heart disease, diabetes, obesity, reduced access to ...

Soaring petrol prices triggered by the ongoing West Asia conflict pushed Pakistan's food delivery riders to the brink on March 13. As per Reuters, it forced many to skip meals and rely on charity to ...

Some states are being hit harder than others this summer as a new COVID-19 strain (XGF) continues to spread. Some regions of the U.S. are still experiencing higher rates of positive COVID tests than ...

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...